PetIQ Inc
NASDAQ:PETQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (51.2), the stock would be worth $25.12 (19% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 63.2 | $30.98 |
0%
|
| 3-Year Average | 51.2 | $25.12 |
-19%
|
| 5-Year Average | 47.5 | $23.32 |
-25%
|
| Industry Average | 18.7 | $9.16 |
-70%
|
| Country Average | 16.7 | $8.18 |
-74%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
PetIQ Inc
NASDAQ:PETQ
|
925m USD | 63.2 | 69.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | 9.9 | 23.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 15.4 | 36.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.4B USD | 15.2 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.2B USD | 8.6 | 28.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 56.4 | 35.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.9B CNY | 12.2 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 16.7 | 22.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.8B CNY | 14.9 | 16.2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -316.6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61B HKD | 0.6 | 7.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
PetIQ Inc
Glance View
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,929 full-time employees. The company went IPO on 2017-07-21. The firm is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels with its branded and distributed medications, as well as health and wellness items, which are further supported by its medications manufacturing facility in Omaha, Nebraska and health and wellness manufacturing facility in Springville, Utah. Its national veterinarian service platform operates in approximately 2,900 retail partner locations in 42 states provides veterinary wellness services. The firm has two segments: Products and Services. The Products segment consists of its manufacturing and distribution businesses. The Services segment consists of veterinary services and related product sales provided by the Company directly to consumers. Its products offering for dogs and cats includes pet Rx medications, OTC medications and wellness products.
